Find information on thousands of medical conditions and prescription drugs.

Psittacosis

more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Arthritis
Arthritis
Bubonic plague
Hypokalemia
Pachydermoperiostosis
Pachygyria
Pacman syndrome
Paget's disease of bone
Paget's disease of the...
Palmoplantar Keratoderma
Pancreas divisum
Pancreatic cancer
Panhypopituitarism
Panic disorder
Panniculitis
Panophobia
Panthophobia
Papilledema
Paraganglioma
Paramyotonia congenita
Paraphilia
Paraplegia
Parapsoriasis
Parasitophobia
Parkinson's disease
Parkinson's disease
Parkinsonism
Paroxysmal nocturnal...
Patau syndrome
Patent ductus arteriosus
Pathophobia
Patterson...
Pediculosis
Pelizaeus-Merzbacher disease
Pelvic inflammatory disease
Pelvic lipomatosis
Pemphigus
Pemphigus
Pemphigus
Pendred syndrome
Periarteritis nodosa
Perinatal infections
Periodontal disease
Peripartum cardiomyopathy
Peripheral neuropathy
Peritonitis
Periventricular leukomalacia
Pernicious anemia
Perniosis
Persistent sexual arousal...
Pertussis
Pes planus
Peutz-Jeghers syndrome
Peyronie disease
Pfeiffer syndrome
Pharmacophobia
Phenylketonuria
Pheochromocytoma
Photosensitive epilepsy
Pica (disorder)
Pickardt syndrome
Pili multigemini
Pilonidal cyst
Pinta
PIRA
Pityriasis lichenoides...
Pityriasis lichenoides et...
Pityriasis rubra pilaris
Placental abruption
Pleural effusion
Pleurisy
Pleuritis
Plummer-Vinson syndrome
Pneumoconiosis
Pneumocystis jiroveci...
Pneumocystosis
Pneumonia, eosinophilic
Pneumothorax
POEMS syndrome
Poland syndrome
Poliomyelitis
Polyarteritis nodosa
Polyarthritis
Polychondritis
Polycystic kidney disease
Polycystic ovarian syndrome
Polycythemia vera
Polydactyly
Polymyalgia rheumatica
Polymyositis
Polyostotic fibrous...
Pompe's disease
Popliteal pterygium syndrome
Porencephaly
Porphyria
Porphyria cutanea tarda
Portal hypertension
Portal vein thrombosis
Post Polio syndrome
Post-traumatic stress...
Postural hypotension
Potophobia
Poxviridae disease
Prader-Willi syndrome
Precocious puberty
Preeclampsia
Premature aging
Premenstrual dysphoric...
Presbycusis
Primary biliary cirrhosis
Primary ciliary dyskinesia
Primary hyperparathyroidism
Primary lateral sclerosis
Primary progressive aphasia
Primary pulmonary...
Primary sclerosing...
Prinzmetal's variant angina
Proconvertin deficiency,...
Proctitis
Progeria
Progressive external...
Progressive multifocal...
Progressive supranuclear...
Prostatitis
Protein S deficiency
Protein-energy malnutrition
Proteus syndrome
Prune belly syndrome
Pseudocholinesterase...
Pseudogout
Pseudohermaphroditism
Pseudohypoparathyroidism
Pseudomyxoma peritonei
Pseudotumor cerebri
Pseudovaginal...
Pseudoxanthoma elasticum
Psittacosis
Psoriasis
Psychogenic polydipsia
Psychophysiologic Disorders
Pterygium
Ptosis
Pubic lice
Puerperal fever
Pulmonary alveolar...
Pulmonary hypertension
Pulmonary sequestration
Pulmonary valve stenosis
Pulmonic stenosis
Pure red cell aplasia
Purpura
Purpura, Schoenlein-Henoch
Purpura, thrombotic...
Pyelonephritis
Pyoderma gangrenosum
Pyomyositis
Pyrexiophobia
Pyrophobia
Pyropoikilocytosis
Pyrosis
Pyruvate kinase deficiency
Uveitis
Q
R
S
T
U
V
W
X
Y
Z
Medicines

In medicine (pulmonology), psittacosis -- also known as parrot disease, parrot fever, and ornithosis -- is a zoonotic infectious disease caused by a bacterium called Chlamydophila psittaci (formerly Chlamydia psittaci) and contracted not only from parrots, macaws, cockatiels and parakeets, but also from pigeons, sparrows, ducks, hens, sea gulls etc. The incidence of infection in canaries and finches is believed to be lower than in psittacine birds.

In birds

In birds, Chlamydophila psittaci infection is referred to as avian chlamydiosis (AC). Infected birds shed the bacteria through feces and nasal discharges, which can remain infectious for several months.

In humans

Symptoms

In humans, after incubation period of 5-14 days, the symptoms of the disease range from inapparent illness to systemic illness with severe pneumonia. It presents chiefly as an atypical pneumonia with influenza-like symptoms like fever, chills, headache, muscle aches, and a dry cough. Pneumonia can be often visualized on a chest X-ray.

Complications in the form of endocarditis, hepatitis, myocarditis, arthritis, keratoconjunctivitis, and neurologic complications (encephalitis) may occasionally occur. Severe pneumonia requiring intensive-care support may also occur. Fatal cases have been reported (less than 1% of cases).

Diagnosis

Diagnosis involves microbiological cultures from respiratory secretions of patients or serologically with a fourfold or greater increase in antibody titers against C. psittaci in blood samples combined with the probable course of the disease.

Epidemiology

Since 1996, fewer than 50 confirmed cases were reported in the United States each year. Many more cases may occur that are not correctly diagnosed or reported.

Bird owners, pet shop employees, and veterinarians are at risk of the infection. Some outbreaks of psittacosis in poultry processing plants have been reported.

Treatment

The infection is treated with antibiotics. Tetracyclines are the drugs of choice for treating patients with psittacosis. Most persons respond to oral therapy (100 mg of doxycycline administered twice a day or 500 mg of tetracycline hydrochloride administered four times a day). For initial treatment of severely ill patients, doxycycline hyclate may be administered intravenously at a dosage of 4.4 mg/kg (2 mg/lb) body weight per day divided into two infusions per day (up to 100 mg per dose). In past years, tetracycline hydrochloride has been administered to patients intravenously (10-15 mg/kg body weight per day divided into four doses per day). Remission of symptoms usually is evident within 48-72 hours. However, relapse can occur, and treatment must continue for at least 10-14 days after fever abates. Although its in vivo efficacy has not been determined, erythromycin probably is the best alternative agent for persons for whom tetracycline is contraindicated (e.g., children aged less than 9 years and pregnant women).

Read more at Wikipedia.org


[List your site here Free!]


Psittacosis at a turkey processing plant - North Carolina, 1989
From Morbidity and Mortality Weekly Report, 7/13/90

On October 14 and 15, 1989, a physician in North Carolina treated two poultry workers from a turkey processing plant (plant A) in North Carolina for possible psittacosis. Following notification on October 16, the Division of Epidemiology, North Carolina Department of Environment, Health, and Natural Resources, conducted a telephone survey of 12 health-care providers in the locality around plant A and identified 32 adults (aged 18-50 years) who had been evaluated for febrile respiratory or gastrointestinal illnesses during the first 2 weeks of October. These persons were considered as having suspected psittacosis, and all were employees at plant A. This report describes the investigation of this outbreak of psittacosis, which was the largest documented in North Carolina since 1956.

Persons with suspected psittacosis were identified by reviews of patient records at the plant clinic, area hospitals, area physicians' offices and clinics, and county health departments and by reviews of information from the Virology/Serology Section of the North Carolina State Laboratory for Public Health. A suspected case of psittacosis was defined as a febrile, respiratory, or gastrointestinal illness with onset during October in an employee at plant A; a confirmed case was defined as a suspected case having at least one of the following laboratory findings: 1) isolation of Chlamydia psittaci from a patient specimen, 2) a fourfold rise in complement-fixation (CF) antibody to Chlamydia group antigen, or 3) a single Chlamydia CF titer of [is greater than or equal to] 32. Acute-phase serum specimens were obtained within 14 days of illness onset; convalescent-phase serum specimens were obtained within 60 days of illness onset.

Sixty suspected cases of psittacosis were identified among workers at plant A. Of these, 40 (67%) met the definition for a confirmed case (Figure 1). Thirty-nine cases were confirmed by serology alone; one also was confirmed by isolation of Chlamydia from a bronchial washing specimen. Records were available for 38 patients; among these patients, the most frequently recorded symptoms were fever (89%) and cough (71%). Other reported symptoms included aches (42%), chest pain (39%), headache (37%), nausea (37%), vomiting (34%), diarrhea (34%), and abdominal pain (18%). Twenty-four (60%) of the 40 persons meeting the case definition were hospitalized.

For the 32 patients with confirmed psittacosis whose temperatures were recorded, the mean maximum body temperature was 39.4 C (103 F) (range: 36.6-41.1 C [98-106 F]; median: 39.4 C [103 F]). The mean maximum white blood cell (WBC) count for the 22 patients whose WBC counts were recorded was 10,600 per [mm.sup.3] (range: 7100-20,900 per [mm.sup.3]; median: 10,100 per [mm.sup.3]). Abnormal chest radiograph results were reported for at least 29 patients, and abnormal liver function tests, for at least seven.

Thirty-eight (95%) of those meeting the case definition worked on the day shift at plant A. Day-shift employees working in the "chilling," "cut-up/debone," and "other" areas of the plant had direct contact only with cleaned and processed turkeys and

TABLE I. Summary -- cases of specified notifiable diseases, United States, cumulative, week ending July 7, 1990 (27th Week)

[TABULAR DATA OMITTED]

[TABULAR DATA OMITTED] appeared to be at lowest risk for meeting the case definition (Table 1). In contrast, workers exposed to turkey viscera in the "offal/truckwash," "U.S. Department of Agriculture (USDA) inspection," and "evisceration" areas were at highest risk. Workers exposed to live birds and their feces in the "live hang" area (where live turkeys are uncrated and hung on the processing line) were at intermediate risk (Table 1).

A plant veterinarian reported that a portion of a flock of tom turkeys processed at plant A during the day shift on September 29 had a carcass condemnation rate of 25% attributed to air sacculities (*); the usual rate of carcass condemnation at plant A is 1%-3%. None of the condemned carcasses or specimens from that flock were retained for necropsy, culture, or further examination. Assuming that exposure occurred on September 29, the mean incubation period for the 40 cases was 15 days (range: 3-31 days; median: 14 days) (Figure 1).

The total compensation disability insurance payments to 34 psittacosis patients was nearly $13,000, and the total medical costs paid for 35 patients was >$124,000, according to information from plant A's workers' compensation insurer.

Editorial Note: Psittacosis ("parrot fever") is caused by the obligate intracellular bacterium C. psittaci, which can infect a variety of mammalian, avian, and reptilian species [1]. Inhalation of infectious aerosols derived from feces, fecal dust, and secretions of C. psittaci-infected animals is believed to be the primary route of infection for most psittacosis patients; percutaneous exposure may be an alternate, but less important, route [1-3]. Most cases of psittacosis are attributed to exposure to infected birds. The source birds can be asymptomatically infected (i.e., carriers) or can show signs of infection, such as anorexia, ruffled feathers, depression, and watery, green droppings.

[TABULAR DATA OMITTED]

Psittacosis is a rarely reported mild illness with no specific signs and symptoms, most often occurring as a sporadic illness in persons having contact with infected cage birds. Occasionally, clusters of cases occur among workers at poultry processing plants or in other settings [1,2]. The diagnosis can be established with certainty only by paired serologic testing or identification of the organism by culture. In North Carolina, the nation's largest turkey-producing state (>50 million turkeys produced each year), fewer than 10 cases of psittacosis per year have been reported in the past 10 years; most cases were related to pet bird exposure.

The clinical and epidemiologic findings of the North Carolina study are comparable to those in other reported outbreaks [1,3]. This report demonstrates that poultry workers having contact with turkey viscera and feces or with live birds are at greatest risk for psittacosis. However, it also supports a recent report from Minnesota [3] in which defeathered, eviscerated, and chilled turkey carcasses may transmit psittacosis. In addition, in both of these outbreaks, the incubation period fpr psittacosis was longer than the 4-14 days commonly cited [1,2].

The principal strategies for the elimination of psittacosis outbreaks among poultry workers are reducing C. psittaci infection in the flocks andprotecting workers from exposure to the organism, even if they work with infected birds. Raising turkey flocks in controlled, indoor environments would minimize the contact between domesticated fowl and C. psittaci-infected wild birds and animals, thereby reducing the risk for infection in the flocks. Testing of flocks for C. psittaci infection is difficult, time consuming, and nonspecific because the majority of strains isolated have no potential for causing human illness. Testing ill birds in flocks for C. psittaci infection and treating infected flocks with chlortetracycline according to USDA regulations before slaughter may reduce worker exposure to this agent. Nevertheless, birds can remain asymptomatically infected after treatment [4] and can transmit infection at slaughter to humans.

As a result of the North Carolina outbreak, the management of plant A initiated an ongoing program of increased flock surveillance for ill turkeys. A short-term program of culturing flocks raised on open land for Chlamydia species and necropsy of any dead birds was also initiated. When chlamydial infection was detected, the implicated flocks were treated with chlortetracycline according to USDA regulations, and plant A employees were strongly encouraged to wear paper face masks when these flocks were processed.

The use of respiratory protection approved by the Mine Safety and Health Administration and by CDC's National Institute for Occupational Safety and Health (NIOSH) may further reduce the inhalation risk of exposure to infectious Chlamydia aerosols [5,6]. However, no research-based information exists on which to recommend an appropriate class of respirator.

References

[1] CDC. Psittacosis surveillance 1975-1984. Atlanta: US Department of Health and Human Services, Public Health Service, 1987.

[2] Schaffner W. Psittacosis. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practice of infectious diseases. New York: John Wiley and Sons, 1979:1476-9.

[3] Hedberg K, White KE, Forfany JC, et al. An outbreak of psittacosis in Minnesota turkey industry workers: implications for modes of transmission and control. Am J Epidemiol 1989;130:569-77.

[4] Benenson AS, ed. Control of communicable diseases in man. 13th ed. Washington, DC: American Public Health Association, 1980.

[5] Office of the Federal Register. Code of federal regulations: occupational safety and health standards. Subpart I. Personal protective equipment. Washington, DC: Office of the Federal Register, National Archives and Records Administration, 1983. (23 CFR [Section] 1910.134).

[6] NIOSH. Guide to industrial respiratory protection. Cincinnati Ohio: US Department of Health and Human Services, Public Health Service, CDC, 1987; DHHS publication no. (NIOSH)87-116.

(*) An avian disorder similar to pleurisy in mammals that is a common but nonspecific manifestation of psittacosis in turkeys.

Reported by: JA Rhyne, MD, Wilmington; L Hunter, DVM, C Staes, MPH, RA Meriwether, MD, JN MacCormack, MD, State Epidemiologist, North Carolina Dept of Environment, Health, and Natural Resources. Div of Field Svcs, Epidemiology Program Office, CDC.

COPYRIGHT 1990 U.S. Government Printing Office
COPYRIGHT 2004 Gale Group

Return to Psittacosis
Home Contact Resources Exchange Links ebay